Tasseel-Ponche, Sophie http://orcid.org/0000-0003-4022-1732
Roussel, Martine
Toba, Monica N. http://orcid.org/0000-0002-4503-2271
Sader, Thibaud
Barbier, Vincent
Delafontaine, Arnaud
Meynier, Jonathan
Picard, Carl
Constans, Jean-Marc
Schnitzler, Alexis
Godefroy, Olivier
Yelnik, Alain Pierre
Funding for this research was provided by:
French Ministry of Health (PHRCI-15-091)
Article History
Received: 7 July 2022
Accepted: 7 February 2023
First Online: 8 March 2023
Declarations
:
: The study was approved by an institutional review board (<i>CPP Nord-Ouest II</i>, Amiens, France: reference: RCB 2016-A00342-49, dated May 13th, 2016) and the French National Agency for Medicines and Health Product Safety (ANSM, Paris, France; reference: June 9, 2016). Personal data will be stored by the investigator in a strictly confidential manner and will not be disclosed to the study sponsor. The study will be conducted in accordance with the protocol and the current version of the Declaration of Helsinki.
: All participants and co-authors will be fully informed about the trial's objectives and will give their written, informed consent for publication of SYNCOMOT’s anonymous data. The model consent form will be provided on request.
: The authors declare that they have no competing interests.